Susan E. Graf

VP of Corp Dev & Strategy, NPS Pharmaceuticals (United States).

Companies

Aardvark Therapeutics, Inc.Board member Feb 12, 2025 to now¹
CG Oncology, Inc.Board member Jan 24, 2024 to now²
Finch Therapeutics Group, Inc.Board member Apr 27, 2021 to Jun 9, 2023³
Epizyme, Inc.Chief Business Officer Apr 26, 2016 to Feb 13, 2018⁴
NPS Pharmaceuticals (United States)VP of Corp Dev & Strategy May 30, 2013 to Feb 24, 2015⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Finch Therapeutics Group, Inc.5,010 shares⁶Jun 9, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 9, 2023Bought 5,010 shares at $0.27 of Finch Therapeutics Group, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAardvark Therapeutics, Inc., Board member
2
SEC EDGARCG Oncology, Inc., Board member
3
SEC EDGARFinch Therapeutics Group, Inc., Board member
4
SEC EDGAREpizyme, Inc., Chief Business Officer
5
SEC EDGARNPS Pharmaceuticals (United States), VP of Corp Dev & Strategy
6
SEC EDGARFinch Therapeutics Group, Inc. shares after the filing of Jun 9, 2023